StockData
Traws Pharma, Inc. logo

Traws Pharma, Inc. (TRAW) stock

TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.23−0.01 (-5.15%)

Close on Nov 19, 2026Market cap $3.53MP/E –Yield –

Traws Pharma free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Traws Pharma's free cash flow for the twelve months ending Dec 31, 2025 was -$20.77M. For fiscal 2025 it was -$20.77M. The highest annual figure on record is $1.35M in fiscal 2012.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$20.77M–
FY2024Dec 31, 2024-$33.44M–
FY2023Dec 31, 2023-$17.95M–
FY2020Dec 31, 2020-$23.09M–
FY2019Dec 31, 2019-$20.89M–
FY2014Dec 31, 2014-$57.88M–
FY2013Dec 31, 2013-$61.99M-4678.5%
FY2012Dec 31, 2012$1.35M–
FY2011Dec 31, 2011-$14.43M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025-$2.76M–
Q4 FY2024Dec 31, 2024-$4.04M–
Q3 FY2024Sep 30, 2024-$11.48M–
Q4 FY2023Dec 31, 2023-$4.43M–
Q4 FY2020Dec 31, 2020-$5.47M–
Q3 FY2020Sep 30, 2020-$5.76M–
Q4 FY2019Dec 31, 2019-$5.36M–

More Traws Pharma figures

See a number that looks wrong?